Rare Diseases 2017 Past Conference Report

With the overwhelming success of the previous conference, Rare Diseases 2017 organizing committee hosted 3rd Annual Congress on Rare Diseases and Orphan Drugs during October 30-November 1, 2017 at San Antonio, USA (Rare Diseases-2017). The conference was marked by the attendance of Editorial Board Members of supported Conference Series LLC Ltd. journals, Scientists, young and brilliant Researchers, Business Delegates and talented Student Communities representing more than 20 countries, who made this conference fruitful and productive. This conference was based on the theme, “Platform to share new treatments and research for Rare Diseases” which included the following scientific tracks:

• Different Types of Rare Diseases
• Clinical Research and Public Awareness
• Mystery Diagnosis of Rare Diseases
• Challenges in Rare Diseases Treatment
• Rare Infectious Diseases and Immune Deficiencies
• Orphan Drugs- Development Trends and Strategies
• Clinical Research on Orphan Drugs
• Orphan Drugs and Ethical Issues
• Future Hereditary of Rare Diseases and Orphan Drugs
• Entrepreneurs Investment Meet
• Rare Diseases in Cancer
• Rare Diseases in Aging
• Patient Organizations and Their Role in Drug Development or Clinical Research

We are thankful to our Honorable Guests for their generous support and suggestions:

• Harsha Rajasimha, George Mason University, USA
• Stella Blackburn, QuintilesIMS, UK
• Anton Yuryev, Elsevier, USA

The conference proceedings were carried out through various scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

• “Rare diseases and orphan drugs: Passion and compassion or growing market with career opportunities for scientists and technologists?” given by Harsha K Rajasimha, George Mason University, USA.
• “Speeding up access to medicines for patients with unmet medical need: Integrating evidence and regulatory pathways” given by Stella Blackburn, QuintilesIMS, UK.
• “Mitochondrial bioenergetics in porphyria: Studies in peripheral blood cells” given by Ashwani K Singal, University of Alabama at Birmingham, USA.
• “OP-101: A novel therapy for treatment of childhood cerebral Adrenoleukodystrophy” given by Sujatha Kannan, Johns Hopkins University School of Medicine, USA.

Various sessions were chaired by Amrik Sahota, Rutgers University, USA; Tony Zbeidy, Orphan-Europe, France.

Conference Series LLC Ltd has taken the privilege of felicitating Rare Diseases 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported the success of this event. The esteemed guests, keynote speakers, well-known researchers, and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Rare Diseases 2017. We are glad to inform that all accepted abstracts for the conference have been published in Conference Series LLC Ltd Journal of Genetic Syndromes & Gene Therapy as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the event, Conference Series LLC Ltd would like to announce the commencement of the "5th Annual Congress on Rare Diseases and Orphan Drugs" during August 29-30, 2018 in Boston, USA.

Let us meet again @ Rare Diseases 2018